Abstract

To evaluate the clinical results combined phacoemulsification and deep sclerectomy (PDS) with the use of mitomicin C (MMC) at different sites. PDS with MMC was performed in patients with open angle glaucoma and cataract. The patients were divided into two groups. In 16 eyes of the first group, MMC (0.2 mg/ml) was applied to subconjunctival area and under the superficial scleral flap. In 16 eyes of the second group, MMC was applied only to the place under the superficial scleral flap. It was compared the effects of different MMC applications in between the groups. Preoperative mean intraocular pressure (IOP) was significantly decreased from 25.84±3.78 mmHg to 16.34±3.33 mmHg (p<0.001). Preoperative best corrected visual acuity (BCVA) was improved from 0.2 to 0.7. Complete final success rates were 67.3% in the first group and 54.2% in the second group. The most common MMC dependent complication was avascular bleb formation which was seen in 5 eyes (31.25%) of the first group and 2 eyes (12.5%) of the second group. Cystic bleb formation was seen in one eye of the second group. The differences in both success rates and complications were statistically significant (p<0.05). MMC is more effective when it is applied to the subconjunctival area together with the place under the superficial scleral flap. However this procedure increases the rate of complications such as avasculer bleb formation.

Highlights

  • In patients with open angle glaucoma and cataract; control of intraocular pressure (IOP) without medication while improving best corrected visual acuity (BCVA) increases quality of life

  • Mitomicin C (MMC) application is one of these techniques that we investigated in our study

  • Khaw et al showed that MMC stops fibroblast growth for 30 days after surgery [17]

Read more

Summary

Introduction

In patients with open angle glaucoma and cataract; control of intraocular pressure (IOP) without medication while improving best corrected visual acuity (BCVA) increases quality of life. Deep sclerectomy and its modifications are nonpenetrating glaucoma surgery (NPGS) that refers to drainage of aqueous humor through a natural intact membrane, namely the trabecular meshwork [1,2] This procedure was first performed by Epstein and Krasnov in the late 1950s and early 1960s. In 1968, Krasnov described an operation and called it " sinusotomy" He suggested unroofing schlemm’s canal without entering anterior chamber [4]. After filtration surgery; proliferation of Tenon capsule fibroblasts cause fibrosis of the bleb and surrounding tissue and decrease the efficacy of the surgery. To avoid this phenomenon the application of antimetabolites has been studied [9, 10]. Mitomicin C (MMC) and 5- fluorouracile (5-FU) are the antimetabolites that are most commonly used

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call